在献血过程中评估出血持续时间和不良捐赠者反应
Caroline Gesu Ngunyi1,2, Michel Noubom3, Jude Eteneneng Enoh1,4
1Department of Medical Laboratory Sciences, Faculty of Health Sciences, University of Buea, Buea, Cameroon.
Vox sanguinis
|April 14, 2025
概括
长时间的出血时间是不良捐赠者反应 (ADR) 的重要因素,再穿孔血液瘤是最常见的. 实施数字静脉探测器可以提高献血的安全性和供应.
科学领域:
- 输血医学 输血医学
- 血液学 血液学 血液学
- 公共卫生 公共卫生
背景情况:
- 输血服务在满足需求和供应方面面临重大挑战. 献血者的不良反应 (ADR) 是重复献血的主要威因素. 这项研究调查了影响喀麦隆ADRs的因素.
- 了解ADRs的原因对于改善捐赠者保留和确保稳定的血液供应至关重要.
研究的目的:
- 在喀麦隆的一家血液银行评估出血的持续时间和不良捐赠者反应 (ADR) 的发生率.
- 确定对ADRs的诱导因素,并建议干预措施以减轻它们.
主要方法:
- 在喀麦隆巴福萨姆地区医院进行了为期24个月的实验研究.
- 在全血献血者中记录了不良献血反应 (ADR),比较出血时间在10分钟内或超过10分钟的献血者,以及接受咨询和未接受咨询的献血者.
主要成果:
- 总体而言,13.9%的捐赠者经历了副作用,重刺相关的血液瘤是最常见的 (5.95%).
- 血流持续时间超过10分钟的捐赠者,相比于在10分钟内出血的捐赠者 (10.6%) (p=0.0013),对副作用的发生率明显更高 (28.9%).
- 捐赠者咨询对不良反应的发生没有显著影响.
结论:
- 长时间的出血时间被确定为ADRs的新型诱导因素,通常与瘤切除术错误 (如重新穿孔血液瘤) 相关.
- 建议在血液银行采用数字静脉探测器设备,以减少不良捐赠者事件,从而增加献血率并缓解血液供应短缺.
更多相关视频
09:41Hemocompatibility Testing of Blood-Contacting Implants in a Flow Loop Model Mimicking Human Blood Flow
Published on: March 5, 2020
8.9K
11:59Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
7.2K
相关概念视频
Blood Transfusion
430
Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
430
Blood Transfusion and Agglutination
10.6K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
10.6K
Rh Blood Group
1.2K
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
1.2K
Bone Marrow Sampling and Transplants
263
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
263
The ABO Blood Group
1.3K
The ABO blood group system is a critical element of transfusion medicine, essential for determining blood compatibility in transfusions and organ transplants. It is based on specific antigens, or agglutinogens, present on the surface of red blood cells (RBCs) and corresponding antibodies, or agglutinins, in the blood plasma.
Antigens in the ABO Blood Group System
Antigens are substances that can trigger an immune response, leading to the production of antibodies. In the ABO blood group system,...
Antigens in the ABO Blood Group System
Antigens are substances that can trigger an immune response, leading to the production of antibodies. In the ABO blood group system,...
1.3K
Disorders of Hemostasis
651
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
651
